Abviva Inc (1084966) SEC Filing 8-K Material Event for the period ending Thursday, May 19, 2011

Abviva Inc

CIK: 1084966

View differences made from one to another to evaluate Abviva Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Abviva Inc.


Assess how Abviva Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Abviva Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2011 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools
CIK: 1084966
Form Type: 8-K Corporate News
Accession Number: 0001102624-11-000343
Submitted to the SEC: Tue Jun 07 2011 2:27:50 PM EST
Accepted by the SEC: Tue Jun 07 2011
Period: Thursday, May 19, 2011
Industry: Medical Laboratories
  1. Bylaw Change
  2. Change in Control
  3. Ending Agreement
  4. Event for Officers
  5. New Agreement
  6. Unregistered Sales

External Resources:

Bookmark the Permalink: